Literature DB >> 30758716

Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression.

Haiyan Yan1, Linlin Ma2, Huiqiang Wang1, Shuo Wu1, Hua Huang3, Zhengyi Gu3, Jiandong Jiang1, Yuhuan Li4.   

Abstract

Influenza is an acute transmissible respiratory infectious disease in humans and animals with high morbidity and mortality. It was reported that luteolin, extracted from Chinese herbs, could potently inhibit influenza virus replication in vitro. To assess the effect and explore the fundamental mechanism of luteolin, we infected several cell lines with two subtypes of influenza A virus (IAV), including A/Jiangxi/312/2006 (H3N2) and A/Fort Monmouth/1/1947 (H1N1) and demonstrated that luteolin suppressed the replication of IAV by cytopathic effect reduction method, qRT-PCR, immunofluorescence and Western blot assays. A time-of-addition assay indicated that this compound interfered with viral replication at the early stage of infection. In addition, we found that luteolin suppressed coat protein I complex expression, which was related to influenza virus entry and endocytic pathway. Overall, our findings demonstrated the antiviral effect of luteolin against IAV and its novel antiviral mechanism.

Entities:  

Keywords:  Antiviral activity; COPI; Influenza A virus; Luteolin

Mesh:

Substances:

Year:  2019        PMID: 30758716     DOI: 10.1007/s11418-019-01287-7

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  31 in total

Review 1.  COPI budding within the Golgi stack.

Authors:  Vincent Popoff; Frank Adolf; Britta Brügger; Felix Wieland
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

2.  Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model.

Authors:  Jiaqi Yan; Qiong Wang; Xuelian Zheng; Hong Sun; Yuqiong Zhou; Daoxia Li; Yong Lin; Xia Wang
Journal:  Biochem Biophys Res Commun       Date:  2011-12-21       Impact factor: 3.575

3.  Cofilin-1 is involved in regulation of actin reorganization during influenza A virus assembly and budding.

Authors:  Ge Liu; Yangfei Xiang; Chaowan Guo; Ying Pei; Yifei Wang; Kaio Kitazato
Journal:  Biochem Biophys Res Commun       Date:  2014-10-14       Impact factor: 3.575

Review 4.  Emerging cellular targets for influenza antiviral agents.

Authors:  Konstantin H Müller; Laura Kakkola; Ashwini S Nagaraj; Anton V Cheltsov; Maria Anastasina; Denis E Kainov
Journal:  Trends Pharmacol Sci       Date:  2011-12-22       Impact factor: 14.819

5.  Dissecting the role of COPI complexes in influenza virus infection.

Authors:  Eileen Sun; Jiang He; Xiaowei Zhuang
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

6.  Dissecting the role of the ARF guanine nucleotide exchange factor GBF1 in Golgi biogenesis and protein trafficking.

Authors:  Tomasz Szul; Robert Grabski; Susan Lyons; Yuichi Morohashi; Svetlana Shestopal; Martin Lowe; Elizabeth Sztul
Journal:  J Cell Sci       Date:  2007-10-23       Impact factor: 5.285

7.  In vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination.

Authors:  Hyung-Jun Kwon; Ha-Hyun Kim; So Young Yoon; Young Bae Ryu; Jong Sun Chang; Kyoung-Oh Cho; Mun-Chual Rho; Su-Jin Park; Woo Song Lee
Journal:  Virol J       Date:  2010-11-10       Impact factor: 4.099

8.  Antivirals in seasonal and pandemic influenza--future perspectives.

Authors:  Michael W Wathen; Mario Barro; Rick A Bright
Journal:  Influenza Other Respir Viruses       Date:  2013-01       Impact factor: 4.380

9.  Golgicide A reveals essential roles for GBF1 in Golgi assembly and function.

Authors:  José B Sáenz; William J Sun; Jae Won Chang; Jinmei Li; Badry Bursulaya; Nathanael S Gray; David B Haslam
Journal:  Nat Chem Biol       Date:  2009-02-01       Impact factor: 15.040

Review 10.  Transport of the influenza virus genome from nucleus to nucleus.

Authors:  Edward C Hutchinson; Ervin Fodor
Journal:  Viruses       Date:  2013-10-02       Impact factor: 5.048

View more
  18 in total

1.  Network Pharmacology Identifies the Mechanisms of Sang-Xing-Zhi-Ke-Fang against Pharyngitis.

Authors:  Yinhe Deng; Quanjiang Li; Menglin Li; Tiantian Han; Guixian Li; Qiong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-12       Impact factor: 2.629

Review 2.  Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).

Authors:  Victor B Hsue; Kyohei Itamura; Arthur W Wu; Elisa A Illing; Kevin J Sokoloski; Bree A Weaver; Benjamin P Anthony; Nathan Hughes; Jonathan Y Ting; Thomas S Higgins
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Research Progress of the Antiviral Bioactivities of Natural Flavonoids.

Authors:  Lin Wang; Junke Song; Ailin Liu; Bin Xiao; Sha Li; Zhang Wen; Yang Lu; Guanhua Du
Journal:  Nat Prod Bioprospect       Date:  2020-09-18

Review 4.  Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.

Authors:  Jyoti Choudhary; Shrivardhan Dheeman; Vipin Sharma; Prashant Katiyar; Santosh Kumar Karn; Manoj Kumar Sarangi; Ankit Kumar Chauhan; Gaurav Verma; Nitin Baliyan
Journal:  Biol Proced Online       Date:  2021-02-01       Impact factor: 3.244

5.  Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools.

Authors:  Haijun Xiong; Zhaowei Dong; Guanhua Lou; Qingxia Gan; Jin Wang; Qinwan Huang
Journal:  Eur J Integr Med       Date:  2020-10-30       Impact factor: 1.314

6.  Ganghuo Kanggan Decoction in Influenza: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation.

Authors:  Yanni Lai; Qiong Zhang; Haishan Long; Tiantian Han; Geng Li; Shaofeng Zhan; Yiwei Li; Zonghui Li; Yong Jiang; Xiaohong Liu
Journal:  Front Pharmacol       Date:  2020-12-10       Impact factor: 5.810

Review 7.  Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.

Authors:  Mohammad Amin Khazeei Tabari; Amin Iranpanah; Roodabeh Bahramsoltani; Roja Rahimi
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

Review 8.  Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71).

Authors:  Salima Lalani; Chit Laa Poh
Journal:  Viruses       Date:  2020-02-06       Impact factor: 5.048

9.  COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.

Authors:  Theoharis C Theoharides
Journal:  Biofactors       Date:  2020-04-27       Impact factor: 6.113

10.  Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MSE analysis.

Authors:  Zi-Jia Zhang; Wen-Yong Wu; Jin-Jun Hou; Lin-Lin Zhang; Fei-Fei Li; Lei Gao; Xing-Dong Wu; Jing-Ying Shi; Rong Zhang; Hua-Li Long; Min Lei; Wan-Ying Wu; De-An Guo; Kai-Xian Chen; Lewis A Hofmann; Zhong-Hua Ci
Journal:  J Integr Med       Date:  2020-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.